Product Details
| Cat.No. | EDC08141 | Product Name | RIPK1 Knockout HEK293T Cell Line |
|---|---|---|---|
| Species | Human | Cell Line | HEK293T |
| Cellosaurus ID | CVCL_0063 | Cell Line Synonyms | Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo |
| NCBI Gene ID | Gene | ||
| Gene Synonyms | AIEFL|IMD57|RIP|RIP-1|RIP1 | Summary |
This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein plays a role in inflammation and cell death in response to tissue damage, pathogen recognition, and as part of developmental regulation. RIPK1/RIPK3 kinase-mediated necrosis is referred to as necroptosis. Genetic disruption of this gene in mice results in death shortly after birth. [provided by RefSeq, Aug 2017]
|
| Associated Diseases | Non-tumor | Digestion Time | 30 sec~1 min |
| Morphology | Adherent | Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA+1% GlutaMax | Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293T | STR Info (Cell bank) Cell Line: HEK293T | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| Amelogenin | X | X | ||||
| CSF1PO | 11 | 12 | 11 | 12 | ||
| D2S1338 | 19 | 19 | ||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 |
| D5S818 | 8 | 9 | 8 | 9 | ||
| D7S820 | 11 | 11 | ||||
| D8S1179 | 11 | 12 | 14 | 12 | 14 | |
| D13S317 | 12 | 14 | 12 | 14 | ||
| D16S539 | 9 | 13 | 9 | 13 | ||
| D18S51 | 17 | 18 | 17 | 18 | ||
| D19S433 | 18 | 18 | ||||
| D21S11 | 28 | 30.2 | 28 | 30.2 | ||
| FGA | 23 | 23 | ||||
| Penta D | 9 | 10 | 9 | 10 | ||
| Penta E | 7 | 15 | 7 | 15 | ||
| TH01 | 7 | 9.3 | 7 | 9.3 | ||
| TPOX | 11 | 11 | ||||
| vWA | 16 | 19 | 16 | 19 | ||
| D6S1043 | 11 | |||||
| D12S391 | 19 | 21 | 19 | 21 | ||
| D2S441 | 11 | 15 | 11 | 15 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying RIPK1 function, RIPK1 Knockout HEK293T Cell Line or RIPK1 overexpression HEK293T Cell Line?
The choice depends on whether you are studying RIPK1's role as a central regulator of TNF receptor signaling, NF-κB activation, apoptosis, and necroptosis or its scaffolding function in the TNFR1 signaling complex. The Knockout line is the standard tool for asking whether RIPK1 is required for these processes — RIPK1 is the principal upstream regulator of necroptosis through RIPK3 recruitment and is essential for many cytokine-induced inflammatory and cell death responses. Overexpression is useful for studying RIPK1's gain-of-function effects or for testing necroptosis pathway components.
For cell death and inflammation research, the EDITGENE RIPK1 Knockout in HEK293T is a high-value mechanistic platform — HEK293T's very high transfection efficiency supports systematic structure-function studies of this complex multi-domain kinase. Rescue with wild-type, kinase-dead (K45A), or RHIM-mutant RIPK1 enables comprehensive dissection of kinase activity, scaffolding, and necroptosis-specific functions. The knockout serves as a critical specificity control for RIPK1 kinase inhibitors (necrostatin-1, GSK2982772, DNL747/SAR443060) in clinical development for inflammatory and neurodegenerative diseases.
Is this RIPK1 Knockout HEK293T Cell Line compatible with overexpression rescue experiments?
Yes. RIPK1 rescue experiments are well-established for cell death pathway research:
• Construct design: use a codon-modified RIPK1 sequence with a small C-terminal tag (FLAG, HA). RIPK1 has N-terminal kinase domain, central intermediate domain (RHIM-containing), and C-terminal death domain — preserve all elements.
• Kinase-dead rescue: the K45A mutation abolishes catalytic activity and is the standard control for distinguishing kinase from scaffolding functions — particularly critical because necroptosis requires RIPK1 kinase activity while NF-κB activation does not.
• RHIM-mutant rescue: tetraAla mutations in the RIP homotypic interaction motif (RHIM) disrupt RIPK3 interaction and abolish necroptosis without affecting NF-κB or apoptosis functions.
• Functional readout: rescue should restore TNF-induced NF-κB activation, apoptosis sensitivity, and necroptosis (phospho-MLKL) responses.
HEK293T transduces with very high efficiency and supports systematic RIPK1 rescue experiments.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.